Member Info for Bewarethebrokers

I�ll take a look at that m8. I�ve had my eye on sirius minerals which looks a fabulous long term bet.

�Deal to be completed first half of 2019 � is the likeliest explanation for the current share price i think we all just want to move on from shire

http://www.bbc.co.uk/news/business-44038049

http://fortune.com/2018/05/08/takeda-buys-shire-62-billion-pharma/

It ended up �39.68 and that is after every report saying that the deal will be done. I can only guess that takeda may want another extension which has pegged back the SP but hopefully the deal will be done tomorrow.

No bank holiday in USA shares are about to hit �40 looking good for takeover

https://asia.nikkei.com/Business/Business-Deals/Takeda-close-to-62bn-deal-for-Shire

From everything i have read, articles, opinions etc i�m getting a sense that somebody else is waiting in the wings and biding their time waiting until the right time before they make a move on shire. I simply cannot see the other big pharmas sitting back and letting takeda get a free run especially after the Q1 figures were released yesterday.things could get very interesting up until the 8th may.

Here is the back end of an article from sky news and the last sentence makes me feel that something is brewing in the background with shire and that the takeda deal is not yet in the bag. Takeda's offer is in the form of cash and shares. Many of Shire's shareholders will not be allowed to hold shares in a Japanese company or even the US paper with which Takeda proposes to make part-payment. They may be receptive to a rival offer with a larger cash element. So watch this space. Shire's remarkable 32-year story might yet have another twist in it.

Shire has agreed to sell, takeda is willing to buy and the japanese banks are willing to lend so i say stop worrying about the share price and roll on 8th may when hopefully we can all move on with a nice profit in our back pockets :-)

Takeda has been granted an extension until the 8th may in which time both parties will be subject to due dilligence. The winning post is in sight but there are still some hurdles to overcome. The market is still not 100% certain that takeda can pull this off hence the cautious share price.

Based on Takeda's share price of �4,923 and the exchange rates of �:�: of 1:151.51 and �:US$ of 1:1.3945 as at the close of business on 23 April 2018, the Revised Proposal implies an equivalent value of approximately �49 per Shire ordinary share comprising the equivalent of: �27.26 in new Takeda shares; and �21.75 in cash. On this basis the Revised Proposal is equivalent to a value of approximately �46 billion for the entire issued and to be issued share capital of the Company. Shire shareholders would also be entitled to any dividends announced, declared, made or paid by Shire in the ordinary course prior to completion of the possible transaction.

�40.78 at close after conversion it�s looking good for the morning. About time :-)

Takeda is nearing a preliminary agreement to acquire Shire Plc after the Japanese drugmaker sweetened its roughly $60 billion bid for the biotechnology behemoth, according to people with knowledge of the matter.

Any idea what has happened? Shares up over 5%

Oh yeah it�s the AGM tomorrow and dividend payment day. thurs for Q1

It could be that with the Q1 results being announced tomorrow that both sides are playing a waiting game.

i was thinking of the massive debt that takeda would be carrying when the shares appear on nasdaq and the impact on the share price hopefully the share price stays around �26

My biggest fear is that if this offer is accepted and we receive �21 in cash and �26 in takeda shares then come the time that the shares start trading on nasqaq they could lose at least 50% of their value. I reckon there will be a stampede to sell the new shares and that worries me more than a no deal situation.

I know everybody is predicting armageddon for shire shares if this takeda takeover does not happen but i disagree. The fact that shire sold part of the business for �1.7m which only accounted for 2% of the turnover shows how valuable shire really is and given the fact that takeda offered �62B and if rejected surely anybody holding shares will want to keep hold of them in case ormskov and co can line up even bigger bidders in the future or even sell parts for huge sums like they did for oncology. I am keeping mine if this takeover fails i�m starting to feel a lot better about shire.